West Pharmaceutical Services Past Earnings Performance
Past criteria checks 4/6
West Pharmaceutical Services's earnings have been declining at an average annual rate of -3.8%, while the Life Sciences industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 3.2% per year. West Pharmaceutical Services's return on equity is 18.1%, and it has net margins of 16.8%.
Key information
-3.84%
Earnings growth rate
-3.25%
EPS growth rate
Life Sciences Industry Growth
26.83%
Revenue growth rate
3.15%
Return on equity
18.15%
Net Margin
16.85%
Last Earnings Update
31 Mar 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How West Pharmaceutical Services makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
BIT:1WST Revenue, expenses and earnings (USD Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
3,221
543
403
74
31 Dec 25
3,074
494
390
74
30 Sep 25
3,018
492
366
71
30 Jun 25
2,960
488
346
69
31 Mar 25
2,896
467
335
68
31 Dec 24
2,893
493
335
69
30 Sep 24
2,876
500
342
69
30 Jun 24
2,877
525
349
70
31 Mar 24
2,929
569
355
69
31 Dec 23
2,950
593
354
68
30 Sep 23
2,927
559
299
66
30 Jun 23
2,866
519
326
63
31 Mar 23
2,884
552
319
61
31 Dec 22
2,887
586
316
59
30 Sep 22
2,909
631
377
56
30 Jun 22
2,929
686
352
56
31 Mar 22
2,881
684
362
55
31 Dec 21
2,832
662
356
53
30 Sep 21
2,681
613
340
52
30 Jun 21
2,523
519
310
51
31 Mar 21
2,326
423
308
48
31 Dec 20
2,147
346
301
47
30 Sep 20
2,037
312
291
44
30 Jun 20
1,945
286
297
41
31 Mar 20
1,888
261
277
40
31 Dec 19
1,840
242
273
39
30 Sep 19
1,792
230
262
39
30 Jun 19
1,767
229
259
39
31 Mar 19
1,745
219
258
41
31 Dec 18
1,717
207
256
40
30 Sep 18
1,711
155
257
40
30 Jun 18
1,677
151
256
39
31 Mar 18
1,627
133
248
38
31 Dec 17
1,599
151
243
39
30 Sep 17
1,566
190
245
39
30 Jun 17
1,544
176
242
39
31 Mar 17
1,535
182
243
38
31 Dec 16
1,509
144
238
37
30 Sep 16
1,487
138
241
37
30 Jun 16
1,454
102
238
37
31 Mar 16
1,426
85
246
36
31 Dec 15
1,400
96
243
34
30 Sep 15
1,390
94
240
32
30 Jun 15
1,401
123
241
33
Quality Earnings: 1WST has high quality earnings.
Growing Profit Margin: 1WST's current net profit margins (16.8%) are higher than last year (16.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1WST's earnings have declined by 3.8% per year over the past 5 years.
Accelerating Growth: 1WST's earnings growth over the past year (16.2%) exceeds its 5-year average (-3.8% per year).
Earnings vs Industry: 1WST earnings growth over the past year (16.2%) exceeded the Life Sciences industry 5.4%.
Return on Equity
High ROE: 1WST's Return on Equity (18.1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/12 01:43
End of Day Share Price
2026/06/12 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
West Pharmaceutical Services, Inc. is covered by 26 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.